Last updated on August 2018

Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation

Brief description of study

This study aims to evaluate the safety of intramuscular (IM) administration of PLX-R18 in subjects with incomplete hematopoietic recovery following HCT.

Clinical Study Identifier: NCT03002519

Contact Investigators or Research Sites near you

Start Over

Tsila Zuckerman, Prof.

Rambam Medical Center
Haifa, Israel
  Connect »